Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 1475 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: 05/31/03
Due: 05/31/04
Phase: N/A
Priority: Normal
Start: -
End: 06/30/01
Due: 06/30/02
Phase: N/A
Priority: Normal
Start: -
End: 10/31/98
Due: 10/31/99
Phase: N/A
Priority: Normal
Start: -
End: 05/31/92
Due: 05/31/93
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 09/30/00
Due: 09/30/01
Phase: N/A
Priority: Normal
Start: -
End: 03/31/89
Due: 03/31/90
Phase: N/A
Priority: Normal
Start: -
End: 06/30/98
Due: 06/30/99
Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
Phase: N/A
Priority: Normal
Start: -
End: 10/31/00
Due: 10/31/01
Phase: N/A
Priority: Normal
Start: -
End: 09/30/96
Due: 09/30/97
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 04/30/89
Due: 04/30/90
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 01/31/95
Due: 01/31/96
Phase: N/A
Priority: Normal
Start: -
End: 02/28/97
Due: 02/28/98
Phase: N/A
Priority: Normal
Start: -
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: -
End: 05/31/90
Due: 05/31/91
Phase: N/A
Priority: Normal
Start: -
End: 11/30/93
Due: 11/30/94
Phase: N/A
Priority: Normal
Start: -
End: 06/30/94
Due: 06/30/95
Phase: N/A
Priority: Normal
Start: -
End: 05/31/93
Due: 05/31/94
Phase: N/A
Priority: Normal
Start: -
End: 07/31/00
Due: 07/31/01
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 02/29/00
Due: 02/28/01
Phase: N/A
Priority: Normal
Start: -
End: 03/31/98
Due: 03/31/99
Phase: N/A
Priority: Normal
Start: -
End: 10/31/98
Due: 10/31/99